The metabolically obese, normal-weight individual revisited
- PMID: 9588440
- DOI: 10.2337/diabetes.47.5.699
The metabolically obese, normal-weight individual revisited
Abstract
Nearly 20 years ago, it was suggested that individuals exist who are not obese on the basis of height and weight, but who, like people with overt obesity, are hyperinsulinemic, insulin-resistant, and predisposed to type 2 diabetes, hypertriglyceridemia, and premature coronary heart disease. Since then it has become increasingly clear that such metabolically obese, normal-weight (MONW) individuals are very common in the general population and that they probably represent one end of the spectrum of people with the insulin resistance syndrome. Available evidence also suggests that MONW individuals could account for the higher prevalence of type 2 diabetes, cardiovascular disease, and other disorders in people with a BMI in the 20-27 kg/m2 range who have gained modest amounts of weight (2-10 kg of adipose mass) in adult life. Specific factors that appear to predispose MONW, as well as more obese individuals, to insulin resistance include central fat distribution, inactivity, and a low VO2max. Because these factors are potentially reversible and because insulin resistance may contribute to the pathogenesis of many diseases, it is our premise that a compelling argument can be made for identifying MONW individuals and treating them with diet, exercise, and possibly pharmacological agents before these diseases become overt, or at least early after their onset. One reason for doing so is that disorders such as type 2 diabetes may be accompanied by irreversible consequences, e.g., ischemic heart disease and nephropathy, at the time of diagnosis or shortly thereafter. Another is that MONW individuals in general should be younger and more amenable and responsive to diet and exercise therapy than are obese patients with established disease. That long-term diet and exercise can work is suggested by two large studies in which, over 5-6 years, the incidence of diabetes was diminished in nonobese and minimally obese patients with impaired glucose tolerance. Based on these considerations and the emerging worldwide epidemic of type 2 diabetes, we believe that studies to assess whether therapies aimed at young MONW individuals can prevent the development of type 2 diabetes and other diseases, including perhaps obesity itself, are urgently needed.
Similar articles
-
Serum magnesium in the metabolically-obese normal-weight and healthy-obese subjects.Eur J Intern Med. 2013 Oct;24(7):639-43. doi: 10.1016/j.ejim.2013.02.014. Epub 2013 Mar 20. Eur J Intern Med. 2013. PMID: 23523313
-
Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals.Obesity (Silver Spring). 2008 Aug;16(8):1881-6. doi: 10.1038/oby.2008.308. Epub 2008 Jun 12. Obesity (Silver Spring). 2008. PMID: 18551117
-
Association of metabolic syndrome components with insulin resistance in normal weight population: the Qazvin Metabolic Diseases study.J Endocrinol Invest. 2015 Oct;38(10):1111-5. doi: 10.1007/s40618-015-0302-y. Epub 2015 May 8. J Endocrinol Invest. 2015. PMID: 25952300
-
Exercise training in obese diabetic patients. Special considerations.Sports Med. 1992 Sep;14(3):171-89. doi: 10.2165/00007256-199214030-00004. Sports Med. 1992. PMID: 1439393 Review.
-
Lean, but not healthy: the 'metabolically obese, normal-weight' phenotype.Curr Opin Clin Nutr Metab Care. 2016 Nov;19(6):408-417. doi: 10.1097/MCO.0000000000000317. Curr Opin Clin Nutr Metab Care. 2016. PMID: 27552473 Review.
Cited by
-
Correlation between tooth decay and insulin resistance in normal weight males prompts a role for myo-inositol as a regenerative factor in dentistry and oral surgery: a feasibility study.Front Bioeng Biotechnol. 2024 Jul 31;12:1374135. doi: 10.3389/fbioe.2024.1374135. eCollection 2024. Front Bioeng Biotechnol. 2024. PMID: 39144484 Free PMC article.
-
Ketosis Suppression and Ageing (KetoSAge) Part 2: The Effect of Suppressing Ketosis on Biomarkers Associated with Ageing, HOMA-IR, Leptin, Osteocalcin, and GLP-1, in Healthy Females.Biomedicines. 2024 Jul 12;12(7):1553. doi: 10.3390/biomedicines12071553. Biomedicines. 2024. PMID: 39062126 Free PMC article.
-
Strong Association of Metabolic Parameters with ADMA and VCAM-1 in Normo-Weight Subjects with Metabolic Syndrome.Diabetes Metab Syndr Obes. 2024 Feb 19;17:833-839. doi: 10.2147/DMSO.S448650. eCollection 2024. Diabetes Metab Syndr Obes. 2024. PMID: 38406267 Free PMC article.
-
Exploring the Multifaceted Landscape of MASLD: A Comprehensive Synthesis of Recent Studies, from Pathophysiology to Organoids and Beyond.Biomedicines. 2024 Feb 8;12(2):397. doi: 10.3390/biomedicines12020397. Biomedicines. 2024. PMID: 38397999 Free PMC article. Review.
-
Role of FGF21 and Leptin for the Diagnosis of Metabolic Health in Children with and without Obesity.J Pers Med. 2023 Dec 3;13(12):1680. doi: 10.3390/jpm13121680. J Pers Med. 2023. PMID: 38138907 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical